Hospital De Galdakao Usansolo — Clinical Trial Site

38 Registered trials

19 Currently recruiting

Organisation

Hospital De Galdakao Usansolo

Location

Galdakao, Spain

Identifier

ORG-100045182

Address

Leku Barrio Labeaga 46 A, 48960, Spain

Departments

-
Angiology and Vascular Sugery
Cardiología
CARDIOLOGY
Cirugía general
CIRUGIA VASCULAR Y ANGIOLOGIA
Digestive
Digestivo
Gastroenterología
Gastroenterology
Hematología
Hematology
Medical Oncology
Neumología
Neumology
Oncología
Oncology
Oncology department
Oncology Service
Pneumology
Rheumatology
Seccion de Hemodinamica
Servicio de Aparato Digestivo, Unidad de Enfermedad Inflamatoria Intestinal
Servicio de Gastroenterología
Servicio de Neumología
Servicio de Reumatología
UROLOGIA

Clinical trials at this site (38)

Search interface

A clinical study of MK-7240 for the treatment of ulcerative colitis (MK-7240-001) Unknown

2025-523766-25-00 Ulcerative colitis 5
Utility of the use of N-acetylcisteine associated with conventional treatment in patients with severe acute alcoholic hepatitis (Maddrey>=32… Pending

2023-510163-35-00 Acute Alcoholic hepatitis 5
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythema… Pending

2025-523670-17-00 Systemic lupus erythematosus 5
Phase II/III randomized controlled open-label trial to evaluate the efficacy and safety of personalized tissue engineered veins in patients … Recruiting

2025-524103-69-00 Chronic Venous Insufficiency 10 2026-06-10
A study to test whether different doses of BI 3000202 help people with systemic lupus erythematosus (SLE) Recruiting

2025-523488-39-00 Systemic lupus erythematosus 4 2026-06-02
VerifyNow to Optimise Platelet Inhibition in Coronary Acute Syndrome (VERONICA) Recruiting

2024-512436-29-00 CARDIOVASCULAR DISEASES 11 2026-03-27
Phase IV, randomized, open-label, open-label, controlled, parallel, multicenter clinical trial in patients who are candidates for smoking ce… Recruiting

2024-518936-36-00 Active smokers 6 2026-01-23
A randomised, double-blind, double-dummy, multicentre, phase III, non inferiority trial of an oral mesalazine formulation in patients with a… Recruiting

2023-509606-30-00 Ulcerative colitis 5 2024-07-24
A Phase 3 Study Comparing JNJ-79635322 and an anti-BCMAxCD3 Bispecific Antibody in Participants with Relapsed or Refractory Multiple Myeloma Recruiting

2025-522007-18-00 Relapsed or Refractory Multiple Myeloma 5 2026-05-27
A study to compare Venetoclax Azacitidine and Quizartinib Vs Venetoclax and Azacitidine in newly diagnosed acute myeloid leukemia patient´s … Recruiting

2025-522979-29-00 Acute myeloid leukemia 5 2026-04-30
A study to test whether nerandomilast can help slow down changes in the lung in people with a family history of pulmonary fibrosis Recruiting

2025-522383-33-00 Pulmonary fibrosis 5 2026-03-23
Efficacy and Safety of Icotrokinra in Adult and Adolescent Participants with Moderately to Severely Active Ulcerative Colitis Recruiting

2025-521381-10-00 Moderately to Severely Active Ulcerative Colitis 5 2025-12-03
EASi-PROTKT™ - A study to test vicadrostat (BI 690517) taken together with empagliflozin in people with type 2 diabetes, high blood pressure… Recruiting

2025-521188-11-00 Type 2 diabetes 5 2025-10-15
Phase Ib-II, non-randomized, open-label study of Tumor Treating Fields (TTFields, 150kHz) concomitant with modFOLFIRINOX for front-line trea… Recruiting

2024-511459-16-00 Histologically confirmed pancreatic adenocarcinoma with 9 2025-10-14
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn’s Disease and Obesity or Overweight:… Recruiting

2024-520210-21-00 Crohn’s Disease 5 2025-09-19
A Study to Test the Effectiveness and Safety of RO7790121 for induction and maintenance therapy in Patients with Moderately to Severely Acti… Recruiting

2024-513053-69-00 Moderately to Severely Active Crohn's Disease (CD) 5 2025-04-16
ANALYSIS OF EFFECTIVENESS OF NEOADJUVANT CHEMOTHERAPY IN THE TREATMENT OF LOCALLY ADVANCED COLON CANCER. Recruiting

2024-519825-39-00 Locally advanced colon cancer (LACC) 4 2025-01-30
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician’s Choice in Patients With Triple Negative Breast Cancer … Recruiting

2024-512279-10-00 Triple Negative Breast Cancer 5 2024-11-25
A follow-up study to test long-term treatment with BI 1015550 in people with pulmonary fibrosis who took part in a previous study with BI 10… Recruiting

2023-507353-15-00 idiopathic pulmonary fibrosis (IPF) 5 2024-09-10
Registry-based randomized trial to determine the role of Oxygen in acute Pulmonary Embolism Recruiting

2024-511959-18-01 Acute Pulmonary Embolism 5 2024-07-01
A Randomized, Multicenter, Placebo-controlled, Phase 3 study to Evaluate the Efficacy and Safety of HER2/neu Peptide GLSI-100 (GP2 + GM-CSF)… Recruiting

2023-504323-25-01 breast cancer 5 2024-03-19
EARLY treatment with Candesartan vs Placebo in asymptomatic GENEtic carriers of Dilated Cardiomyopathy (EARLY-GENE trial) Recruiting

2023-507029-40-00 Genetic carriers of dilated cardiomyopathy causing vari 5 2022-05-09
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine-Based Therapy Ended

2022-501024-20-00 ER+/HER2- Early Breast Cancer 5 2023-07-25
PEITHO-3 - A reduced dose of thrombolytic treatment for patients with intermediate high-risk acute pulmonary embolism: a randomized controll… Ended

2024-511321-54-00 intermediate-high-risk acute pulmonary embolism 5 2021-08-04